logo-loader
viewPrevail Partners

Prevail Partners President reveals investment thesis when looking at life sciences companies

Prevail Partners President Mary Schaheen sat down with Proactive’s Christine Corrado at the BIO CEO & Investor Conference in New York. The Philadelphia-based 'private equity-esque' fund focuses strictly on life sciences, with investments in almost 60 companies.

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

Full interview: CytoDyn's therapy used to treat New York coronavirus...

CytoDyn Inc (OTCMKTS:CYDY) CEO Nader Pourhassan tells Proactive the biotech shared positive test results today from seven coronavirus (COVID-19) patients who were treated with the company’s drug leronlimab at a leading medical center in the New York City area. Pourhassan, together diagnostics...

1 day, 23 hours ago

2 min read